2020
DOI: 10.1111/dth.14170
|View full text |Cite
|
Sign up to set email alerts
|

Maculopapular eruptions associated to COVID ‐19: A subanalysis of the COVID‐Piel study

Abstract: Background A previous study has defined the maculopapular subtype of manifestations of COVID‐19. Objectives To describe and classify maculopapular eruptions associated with COVI‐19. Methods We carried out a subanalysis of the maculopapular cases found in the previous cross‐sectional study. Using a consensus, we defined 7 clinical patterns. We described patient demographics, the therapy received by the patient and the characteristics of each p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
51
0
7

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(58 citation statements)
references
References 38 publications
0
51
0
7
Order By: Relevance
“…Erythematous papules may also be arranged in a morbilliform pattern [23]. In a subanalysis of the COVID-Piel Study [4] on maculopapular eruptions including also purpuric, erythema multiforme-like, pityriasis rosea-like, erythema elevatum diutinum-like and perifollicular eruptions, morbilliform exanthems were the most frequent maculopapular pattern ( n = 80/176, 45.5%) [24]. This study showed that in most cases lesions were generalized, symmetrical and started on the trunk with centrifugal progression.…”
Section: Confluent Erythematous/maculopapular/morbilliform Rashmentioning
confidence: 99%
See 1 more Smart Citation
“…Erythematous papules may also be arranged in a morbilliform pattern [23]. In a subanalysis of the COVID-Piel Study [4] on maculopapular eruptions including also purpuric, erythema multiforme-like, pityriasis rosea-like, erythema elevatum diutinum-like and perifollicular eruptions, morbilliform exanthems were the most frequent maculopapular pattern ( n = 80/176, 45.5%) [24]. This study showed that in most cases lesions were generalized, symmetrical and started on the trunk with centrifugal progression.…”
Section: Confluent Erythematous/maculopapular/morbilliform Rashmentioning
confidence: 99%
“…This study showed that in most cases lesions were generalized, symmetrical and started on the trunk with centrifugal progression. In the same subanalysis, hospital admission due to pneumonia was very frequent (80%) in patients with a morbilliform pattern [24]. In this group, the main differential diagnoses are represented by exanthems due to viruses other than SARS-CoV-2 and drug-induced cutaneous reactions.…”
Section: Confluent Erythematous/maculopapular/morbilliform Rashmentioning
confidence: 99%
“…High D-Dimer was reported to associate with maculopapular eruptions. 24 Increasing D-dimer might be related to the circulatory disorder of the multiple organ system including skin caused by the virus and the pathogenesis of skin changes such as vascular occlusive dermatosis in COVID-19 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Skin lesions linked with COVID-19 are noteworthy ( 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 ). Cutaneous findings with the infection itself may produce skin changes which have been classified into 6 categories with three distinct indicative patterns: vesicular (varicella-like), vasculopathic, and chilblains-like (including “COVID fingers” or “COVID toes”) ( Fig 1 , Fig 2 , Fig 3 ) plus three less suggestive ones: dermatitic, maculopapular, and urticarial morphologies ( Fig.…”
Section: Cutaneousmentioning
confidence: 99%
“…A Spanish study classified the cutaneous manifestations associated with COVID-19 five clinical patterns: acral erythema with vesicles or pustules (pseudo-chilblain), other vesicular eruptions (9%), urticarial lesions (19%), maculopapular eruptions (47%) and livedo or necrosis (6%) ( 19 ). From these maculopapular eruptions seven maculopapular patterns were delineated: 1) morbilliform, 2) other maculopapular, 3) purpuric, 4) erythema multiforme-like, 5) pityriasis rosea-like, 6) erythema elevatum diutinum-like, and 7) perifollicular ( 20 ).
Fig 1 Vasculopathic COVID-19 skin, a distinct indicative pattern (COVID-19 with dermatologic manifestations and implications: An unfolding conundrum.
…”
Section: Cutaneousmentioning
confidence: 99%